105 related articles for article (PubMed ID: 32463170)
1. Outcomes of immunoglobulin-associated mesangiocapillary glomerulonephritis: A South African experience.
Chothia MY; Panday AS; Coetzee L; Bates W
Nephrology (Carlton); 2020 Oct; 25(10):765-774. PubMed ID: 32463170
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.
Okpechi IG; Dlamini TA; Duffield M; Rayner BL; Moturi G; Swanepoel CR
PLoS One; 2014; 9(11):e113302. PubMed ID: 25411791
[TBL] [Abstract][Full Text] [Related]
3. Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis.
Ayodele OE; Okpechi IG; Swanepoel CR
Nephrology (Carlton); 2010 Jun; 15(4):482-90. PubMed ID: 20609103
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
[TBL] [Abstract][Full Text] [Related]
5. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
Bomback AS; Santoriello D; Avasare RS; Regunathan-Shenk R; Canetta PA; Ahn W; Radhakrishnan J; Marasa M; Rosenstiel PE; Herlitz LC; Markowitz GS; D'Agati VD; Appel GB
Kidney Int; 2018 Apr; 93(4):977-985. PubMed ID: 29310824
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in mesangioproliferative glomerulonephritis.
Vikse BE; Bostad L; Aasarød K; Lysebo DE; Iversen BM
Nephrol Dial Transplant; 2002 Sep; 17(9):1603-13. PubMed ID: 12198211
[TBL] [Abstract][Full Text] [Related]
7. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
[TBL] [Abstract][Full Text] [Related]
8. Validation of a Histologic Scoring Index for C3 Glomerulopathy.
Caravaca-Fontán F; Trujillo H; Alonso M; Díaz-Encarnación M; Cabello V; Ariceta G; Quintana LF; Marco H; Barros X; Ramos N; Rodríguez-Mendiola N; Cruz S; Fernández-Juárez G; Rodríguez E; de la Cerda F; Pérez de José A; López I; Fernández L; Pérez Gómez V; Ávila A; Bravo L; Lumbreras J; Allende N; Sanchez de la Nieta MD; Olea T; Melgosa M; Huerta A; Miquel R; Mon C; Fraga G; de Lorenzo A; Draibe J; González F; Shabaka A; Illescas ML; Calvo C; Oviedo V; Da Silva I; Goicoechea de Jorge E; Caravaca F; Praga M;
Am J Kidney Dis; 2021 May; 77(5):684-695.e1. PubMed ID: 33359150
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and risk factors in patients with crescentic glomerulonephritis: a multicenter cohort study.
Su X; Song R; Li S; Guo W; Guo X; Qiao X; Wang L
J Nephrol; 2023 May; 36(4):1027-1035. PubMed ID: 36786975
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of crescentic lesions in immunoglobulin A nephropathy.
Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH
Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867
[TBL] [Abstract][Full Text] [Related]
11. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
[TBL] [Abstract][Full Text] [Related]
12. Hypertension, end-stage renal disease and mesangiocapillary glomerulonephritis in methamphetamine users.
Jones ES; Rayner BL
S Afr Med J; 2015 Mar; 105(3):199-201. PubMed ID: 26294827
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in glomerular diseases with crescents.
Yeter HH; Gonul I; Demirel E; Korucu B; Derici U
Rom J Intern Med; 2019 Sep; 57(3):254-261. PubMed ID: 31075086
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of lupus nephritis patients with different proportions of crescents.
Zhang W; Yuan M; Hong L; Zhou Q; Chen W; Yang S; Yang Q; Chen W; Yu X
Lupus; 2016 Dec; 25(14):1532-1541. PubMed ID: 27060063
[TBL] [Abstract][Full Text] [Related]
15. Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.
Lomax-Browne HJ; Medjeral-Thomas NR; Barbour SJ; Gisby J; Han H; Bomback AS; Fervenza FC; Cairns TH; Szydlo R; Tan SJ; Marks SD; Waters AM; Appel GB; D'Agati VD; Sethi S; Nast CC; Bajema I; Alpers CE; Fogo AB; Licht C; Fakhouri F; Cattran DC; Peters JE; Cook HT; Pickering MC
Clin J Am Soc Nephrol; 2022 Jul; 17(7):994-1007. PubMed ID: 35777834
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes for primary glomerulonephritis: New Zealand Glomerulonephritis Study.
Chembo CL; Marshall MR; Williams LC; Walker RJ; Lynn KL; Irvine J; Pilmore HL
Nephrology (Carlton); 2015 Dec; 20(12):899-907. PubMed ID: 26096749
[TBL] [Abstract][Full Text] [Related]
17. Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.
Crnogorac M; Horvatic I; Toric L; Galesic Ljubanovic D; Tisljar M; Galesic K
Int Urol Nephrol; 2017 Aug; 49(8):1419-1431. PubMed ID: 28646482
[TBL] [Abstract][Full Text] [Related]
18. Doubling of serum creatinine: is it appropriate as the endpoint for CKD? Proposal of a new surrogate endpoint based on the reciprocal of serum creatinine.
Takeuchi N; Takenoshita E; Kato F; Terajima T; Ogawa M; Suzuki S; Fujii T; Kobayashi E; Sakurada T; Satoh N; Ueda S
Clin Exp Nephrol; 2011 Feb; 15(1):100-7. PubMed ID: 21058043
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
[TBL] [Abstract][Full Text] [Related]
20. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
